AOD-9604 Dosing AOD-9604 is administered as a daily subcutaneous injection
Better outcomes usually come from staying committed to your broader health plan, attending follow-up visits as recommended, and tracking how you feel over time
The most common switches are: POM to P : Occurs when the medicine no longer meets the legal criteria requiring prescription control (e.g., the risk of misuse or danger to human health without medical supervision is minimal)
116:109741 Thymosin beta-4 and peptide-mediated cellular signaling pathways Dou Y, Lee A, Zhu L, Morton J, Ladiges W., Aging Pathobiology and Therapeutics , 2020
Animal studies suggest it may accelerate repair of muscle, tendon, and ligament injuries while reducing inflammation and soreness, allowing faster return to training
Its role in research is exploratory and focused on mechanistic understanding rather than on therapeutic or clinical outcomes